1. Home
  2. BLLN vs BELFB Comparison

BLLN vs BELFB Comparison

Compare BLLN & BELFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BLLN

BillionToOne Inc.

N/A

Current Price

$83.95

Market Cap

3.9B

Sector

Health Care

ML Signal

N/A

Logo Bel Fuse Inc. Class B

BELFB

Bel Fuse Inc. Class B

HOLD

Current Price

$259.36

Market Cap

3.5B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLLN
BELFB
Founded
2016
1949
Country
United States
United States
Employees
713
4964
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BLLN
BELFB
Price
$83.95
$259.36
Analyst Decision
Buy
Strong Buy
Analyst Count
7
4
Target Price
$126.71
$174.25
AVG Volume (30 Days)
575.7K
208.1K
Earning Date
05-06-2026
04-29-2026
Dividend Yield
N/A
0.11%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$46.29
$9.74
Revenue Next Year
$30.14
$6.34
P/E Ratio
N/A
$42.80
Revenue Growth
N/A
N/A
52 Week Low
$61.96
$70.87
52 Week High
$138.70
$308.27

Technical Indicators

Market Signals
Indicator
BLLN
BELFB
Relative Strength Index (RSI) 49.23 47.15
Support Level $79.33 $132.17
Resistance Level $97.36 N/A
Average True Range (ATR) 8.45 15.44
MACD 0.37 -4.05
Stochastic Oscillator 35.65 26.06

Price Performance

Historical Comparison
BLLN
BELFB

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

About BELFB Bel Fuse Inc. Class B

Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.

Share on Social Networks: